Condition: Uterine Cervical Neoplasms · Chemoradiotherapy · Adjuvant Chemotherapy · Sponsor: Fourth Affiliated Hospital of Guangxi Medical University
This study carried out a prospective, randomized, controlled clinical study under the background of intensity-modulated radiation therapy and three-dimensional afterloading therapy. By comparing simultaneous intensity-modulated radiotherapy and chemotherapy combined with adjuvant chemotherapy and simultaneous intensity-modulated radiotherapy and chemotherapy alone, based on the 2018 FIGO staging The clinical efficacy of locally advanced cervical cancer further clarifies the role of adjuvant chemotherapy in locally advanced cervical cancer.
This description comes directly from the study's public registry record.
Huang haixin · 13507726193 · 13507726193@163.com
Feng chengjun · 18877279562 · leymj@163.com
Always discuss trial participation with your own doctor first.
| the Fourth Affiliated Hospital of Guangxi Medical University | Liuzhou, Guangxi, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05735145